Tumors with diminished formation of the CXCL12–KRT19 coating showed increased numbers of infiltrating CD3+ T cells (Fig. 5A) and slower growth rates than the tumors formed with PDA cells expressing TGM2 in both types of hosts (Fig. 5B). The gene discussed is CXCL12; the disease is Patent ductus arteriosus.